Olaratumab (Anti-PDGFRA / CD140a)
Olaratumab (IMC-3G3; LY3012207) is a fully human IgG1 monoclonal antibody directed against the platelet-derived growth factor receptor alpha (PDGFR alpha) with potential antineoplastic activity. MW: 145.5 kD.
Trivial name | IMC-3G3, LY3012207 |
Catalog Number | A2379 |
CAS# | 1024603-93-7 |
Size | 1mg*25 |
Supplier Page | http://www.selleckchem.com/products/olaratumab-anti-pdgfra-cd140a.html |